United Kingdom: Patent

For businesses seeking external funding, intellectual property can be one of the most important assets on the balance sheet. Whether a company is raising seed investment, securing venture capital funding, attracting...

As artificial intelligence becomes embedded in product design, data infrastructure, and everyday workflows, organisations face a critical shift from theoretical AI governance frameworks to continuous operational decision-making.

The Patent Mediation and Arbitration Centre of the Unified Patent Court has launched its Case Management System, offering parties a new confidential and expedited pathway for resolving patent disputes across Europe and beyond.

Over five years after Brexit, many intellectual property agreements drafted before the UK's EU departure may contain ambiguous territorial scope provisions.

The HEVC Advance Patent Pool has become a focal point for standard-essential patent disputes, with major technology companies facing coordinated litigation across multiple jurisdictions. As licensors pursue enforcement through both the Unified Patent Court and national courts, questions arise about whether offered licensing terms truly meet FRAND obligations and how companies should navigate this complex multi-forum landscape.

As set out in the EPO’s recently-released Technology Dashboard 2025 (its annual summary of key figures and trends in patent activity), growth in the field of battery technologies continues unabated, with the number...

The Unified Patent Court operates on a strict "front-loaded" procedural principle requiring parties to present their complete case at the earliest stage. Late-filed evidence, new invalidity grounds...

Patentees generally want to encompass both their core invention and a small amount of white space around it. In some fields, this is relatively straightforward.

Abstract: EPO decision T 1396/23 confirms that functional foods can support medical‑use claims when their therapeutic effects are credible, data‑backed, and tied to recognised clinical outcomes. This provides some comfort to innovators in this space, but many questions of implementation remain unanswered.